Mastenitis for the treatment of cow mastitis 3.6g

DESCRIPTION

Mastenit is a veterinary drug for the treatment of cow mastitis. In appearance, the drug is a thick suspension from white to light gray.

COMPOSITION

Mastenit in 1 syringe 3.6 g contains cloxacillin (in terms of base) - 600 mg as an active ingredient, and auxiliary substances: benzathine diacetate, butylhydroxytoluene (ionol), colloidal anhydrous silicon dioxide (Aerosil 300) and liquid paraffin.

PHARMACOLOGICAL PROPERTIES

Mastenit refers to antibacterial drugs of the group of semi-synthetic penicillins.

Cloxacillin - the active ingredient of Mastenit has a wide spectrum of antibacterial action, is active against gram-positive bacteria usually isolated from udder secretions during the dry period, including Streptococcus spp (including Streptococcus agalactiae), Staphylococcus spp (including strains resistant to peninsula) ) and Corynebacterium pyogenes.

The mechanism of antibacterial action is to suppress the functional activity of bacterial transpeptidase enzymes involved in binding of the main component to the inaccurate wall of microorganisms - peptidoglycan, which leads to the death of bacteria.

Mastenit creates a high level of antibiotic in the udder tissues, which ensures the therapeutic effect of the drug in dry cows lasting at least 7 weeks.

The drug belongs to low-hazard substances (hazard class 4 according to GOST 12.1.007-76).

DOSAGE AND APPLICATION

Mastenit is used once for the treatment of cow mastitis before transferring to the dry period, but no later than 42 days before the expected calving.

The use of the drug during pregnancy is allowed. The drug is not intended for use during lactation. The drug is not intended for use in young animals.

Mastenit is administered to cows just before starting. Milk must be milked before the administration of Mastenit. The outside of the nipple is wiped with a 70% alcohol solution or a special antiseptic napkin.

For calm animals, only the upper part of the lid covering the syringe cannula is removed, and for restless animals it is completely removed. After that, the cannula of the syringe is inserted into the opening of the nipple and, by gently pressing the plunger, the drug is injected. The contents of one syringe are injected into each quarter of the udder.

SPECIAL INSTRUCTIONS

When working with Mastenit, you should follow the general rules of personal hygiene and safety measures provided for when working with medicines.

People with hypersensitivity to the components of the drug should avoid direct contact with the drug. When working with the drug, it is prohibited to drink, smoke and eat. After handling the medicinal product, wash your hands with soap and water. Empty packages from under the medicinal product must not be used for domestic purposes, they must be disposed of with household waste.

In case of accidental contact of the medicinal product with the skin or mucous membranes of the eyes, rinse immediately with plenty of water. In case of allergic reactions or accidental ingestion of the drug into the human body, you should immediately contact a medical institution (you should have instructions for use of the drug or a label with you).

CONTRAINDICATIONS

Contraindication to use is hypersensitivity to cloxacillin or any other component of the drug. Mastenit is prohibited for lactating cows.

SIDE EFFECTS

Side effects and complications when using Mastenit, in accordance with the instructions, have not been established. In the event of allergic reactions, the use of the drug is discontinued and antihistamines and symptomatic therapy are prescribed.

SHELF LIFE AND STORAGE

The shelf life of the medicinal product, subject to the storage conditions in the manufacturer's sealed packaging, is 2 years from the date of production; after the first opening of the primary packaging, it cannot be stored. It is forbidden to use Mastenit after the expiration date.

Store the medicinal product in the manufacturer's closed packaging, separately from food and feed, in a place protected from direct sunlight at a temperature of 0 В° C to 25 В° C.

PACKAGING

Mastenit is produced packaged in 3.6 g each in polymer syringes with a cannula for intracisternal administration, sealed with protective caps. The protective cap consists of an upper and a lower part to obtain cannulas of different lengths. Each syringe is supplied with a sterile alcohol wipe and instructions for use.

Specifications

Item segment

New

Bonus points

0

KolVUP

144

Manufacturer

Nita-Farm

Teaser

for the treatment of mastitis of cows before transfer to the dry period